| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $78.2M | $69.4M | $55.7M |
| YoY Revenue Growth % | +12.7% | +24.6% | — |
| Gross Profit | $30.7M | $27.1M | — |
| Gross Margin % | 39.2% | 39.0% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$2.5M | -$1.8M | -$10.5M |
| Operating Margin % | -3.2% | -2.6% | -18.9% |
| Net Income (GAAP) | -$3.9M | -$4.5M | -$9.9M |
| EBITDA (Normalized) | -$2.2M | -$1.6M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $996.1K | -$3.1M | -$2.5M |
| Capital Expenditures (CapEx) | $320.6K | $251.8K | — |
| Free Cash Flow (FCF) | $675.4K | -$3.3M | -$2.5M |
| FCF Margin % | 0.9% | -4.8% | -4.5% |
| Return on Invested Capital (ROIC %) | -18.8% | -14.7% | — |
| Cash & Short-Term Equivalents | $3.0M | $2.1M | — |
| Total Debt (Short + Long Term) | $6.2M | $9.2M | — |
| Total Stockholders' Equity | $7.3M | $2.4M | — |